Stephen Chau has extensive experience in biochemistry and protein sciences, having held positions at notable companies in the biotechnology industry. At Entrada Therapeutics, Stephen served as a Research Associate II and Senior Research Associate from September 2019 to December 2022, focusing on oligonucleotide and protein analytical routine quality control. Previous roles include Associate Research Scientist at Bristol-Myers Squibb, Research Associate at Sanofi Genzyme, and Associate Scientist III at Biogen. Stephen has contributed to drug development through protein purification and analytical studies, as well as the incorporation of novel techniques in production processes. Currently, Stephen is a Scientist II at Merck, conducting biochemical and biophysical studies to optimize ligand interactions with target proteins. Stephen earned a Bachelor of Science in Biochemistry from Northeastern University in 2016.
This person is not in the org chart
This person is not in any teams
This person is not in any offices